Skip to content

Comparison of Effect of Airway Nebulization with 2% Lignocaine,nebulised 1mcg/kg dexmedetomidine and 0.25%Ropivacaine on Intubation and Extubation Response in Patients Undergoing Surgery under General Anesthesia

Comparison of Effect of Airway Nebulization with lignocaine 2% nebulized Dexmedetomidine and Ropivacaine 0.25% on Intubation and Extubation response in patients undergoing surgery under general Anaesthesia: A Randomized Double Blind clinical trial�

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/09/045292
Enrollment
90
Registered
2022-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: dexmedetomidine: Dexmedetomidine at a dose of 1 �µg/kg (mixed with saline to a total volume of 5 ml) nebulisation was administered Control Intervention1: lignocaine: 5 ml of 2% lignoc

Sponsors

srilakshmi narayana institute of medical sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective surgery under general anesthesia with endotracheal intubation cases

Exclusion criteria

Exclusion criteria: ASA 3 or more Patients with history of risk factors for perioperative aspiration of gastric contents, history of chronic obstructive pulmonary disease, asthma, history of recent respiratory infections, duration of surgery more than 3 h were excluded from the study. Pregnant and lactating mother Anticipated difficult airway

Design outcomes

Primary

MeasureTime frame
attenuation of intubation responseTimepoint: MAP, HR, and SPO2 at; Baseline (T1) Upon tracheal intubation (T2) Upon anesthetic withdrawal (T3) Upon eye opening on verbal commands (T4) Upon tracheal extubation (T5) Two min after extubation (T6).

Secondary

MeasureTime frame
extubation responseTimepoint: up on end of surgery

Countries

India

Contacts

Public ContactE Lavanya

srilakshmi narayana institute of medical sciences

dr.lavanya08@gmail.com09629181969

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026